Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients

Journal of Nephropathology

Volumn 1, Issue 3, 2012, Pages 123-125

  Solati, Mehrdad ^a   Mahboobi, Hamid Reza ^a  

^a HORMOZGAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chronic renal failure; Dyslipidemia; Paraoxonase

Indexed keywords

EID: 84874687547     PISSN: 22518363     EISSN: 22518819     Source Type: Journal    
DOI: 10.5812/nephropathol.8106     Document Type: Editorial

References (19)

1. Vaziri ND. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol. 2006;290(2):F262-72.
2. Cases A, Coll E. Dyslipidemia and the progression of renal disease in chronic renal failure patients. Kidney Int Suppl. 2005;(99):S87-93.
3. Davidson M. Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation. Prev Cardiol. 2005;8(4):244-9.
4. Precourt LP, Amre D, Denis MC, Lavoie JC, Delvin E, Seidman E, et al. The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis. 2011;214(1):20-36.
5. Azizi F, Raiszadeh F, Solati M, Etemadi A, Rahmani M, Arabi M. Serum paraoxonase 1 activity is decreased in thyroid dysfunction. J Endocrinol Invest. 2003;26(8):703-9.
6. Raiszadeh F, Solati M, Etemadi A, Azizi F. Serum paraoxonase activity before and after treatment of thyrotoxicosis. Clin Endocrinol (Oxf). 2004;60(1):75-80.
7. Koren-Gluzer M, Aviram M, Meilin E, Hayek T. The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates β-cell insulin release. Atherosclerosis. 2011;219(2):510-8.
8. Martinez-Salazar MF, Almenares-Lopez D, Garcia-Jimenez S, Sanchez-Aleman MA, Juantorena-Ugas A, Rios C, et al. Relationship between the paraoxonase (PON1) L55M and Q192R polymorphisms and obesity in a Mexican population: a pilot study. Genes Nutr. 2011;6(4):361-8.
9. Kordi-Tamandani DM, Hashemi M, Sharifi N, Kaykhaei MA, Torkamanzehi A. Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome. Mol Biol Rep. 2012;39(2):937-43.
10. She ZG, Chen HZ, Yan Y, Li H, Liu DP. The human paraoxonase gene cluster as a target in the treatment of atherosclerosis. Antioxid Redox Signal. 2012;16(6):597-632.
11. Azizi F, Rahmani M, Raiszadeh F, Solati M, Navab M. Association of lipids, lipoproteins, apolipoproteins and paraoxonase enzyme activity with premature coronary artery disease. Coron Artery Dis. 2002;13(1):9-16.
12. Prakash M, Phani NM, Kavya R, Supriya M. Paraoxonase: Its antiatherogenic role in chronic renal failure. Indian J Nephrol. 2010;20(1):9-14.
13. Saeed SA, Elsharkawy M, Elsaeed K, Fooda O. Paraoxonase- 1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients. Hemodial Int. 2008;12(4):471-9.
14. Varga E, Seres I, Harangi M, Karpati I, Koncsos P, Sztanek F, et al. Low High-Density Lipoprotein Cholesterol Is Not Responsible for Decreased Paraoxonase Activity in Chronic Renal Failure. Kidney Blood Press Res. 2012;35(4):265-72.
15. Prakash M, Shetty JK, Rao L, Sharma S, Rodrigues A, Prabhu R. Serum paraoxonase activity and protein thiols in chronic renal failure patients. Indian J Nephrol. 2008;18(1):13-6.
16. Ece A, Atamer Y, Gurkan F, Davutoglu M, Bilici M, Tutanc M, et al. Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure. Pediatr Nephrol. 2006;21(2):239-45.
17. Paragh G, Seres I, Balogh Z, Varga Z, Karpati I, Matyus J, et al. The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia. Nephron. 1998;80(2):166-70.
18. Gugliucci A, Lunceford N, Kinugasa E, Ogata H, Schulze J, Kimura S. Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients. Clin Chim Acta. 2007;384(1-2):105-12.
19. Dantoine TF, Debord J, Charmes JP, Merle L, Marquet P, Lachatre G, et al. Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol. 1998;9(11):2082-8.